文献速递呼吸道感染

儿童使用抑酸剂与社区获得性肺炎风险

The risk of community-acquired pneumonia in children using gastric acid suppressants.
PubMed 文献 · Eur Respir J · 2021-10-07

该队列研究基于英国临床实践研究数据链,纳入1月龄至18岁使用抑酸剂的儿童84 868例并匹配325 329例未暴露儿童,评估社区获得性肺炎(CAP)风险。当前使用质子泵抑制剂(PPI)和组胺-2受体拮抗剂(H2RA)均与CAP风险增加相关,调整后风险比分别为2.05(95%CI 1.90-2.22)和1.80(95%CI 1.67-1.94);长期使用及合并呼吸系统疾病者风险更高,停药后7个月内风险仍持续增加。

要点

  • 儿童当前使用PPI或H2RA与CAP风险增加相关,调整后风险比分别为2.05和1.80。
  • 合并呼吸系统疾病的患儿使用抑酸剂后CAP风险更高。
  • 长期使用(≥211天)比短期使用(<31天)的CAP风险显著更高,停药后7个月内风险仍增加。

核心结论

  • 儿童使用抑酸剂与CAP风险增加约两倍相关,且风险随长期使用和呼吸系统疾病而升高,停药后仍持续增加。

研究设计与样本

  • 基于英国临床实践研究数据链的队列研究,纳入1月龄至18岁使用抑酸剂的儿童84 868例,匹配至多4倍未暴露儿童325 329例,采用时变Cox比例风险模型估计CAP风险。

主要发现

  • 当前使用PPI的调整后风险比为2.05(95%CI 1.90-2.22),当前使用H2RA的调整后风险比为1.80(95%CI 1.67-1.94)。
  • 合并呼吸系统疾病的患者使用抑酸剂后CAP风险更高。
  • 长期使用PPI和H2RA(≥211天)相比短期使用(<31天)CAP风险显著更高。
  • 停用抑酸剂后,CAP风险在随后7个月内仍保持增加。

临床怎么用

  • 对儿童处方抑酸剂时应评估CAP风险,尤其对于合并呼吸系统疾病或需长期用药者。
  • 长期使用抑酸剂的儿童停药后仍需关注CAP风险,直至停药后7个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the increased use of acid suppressants, significant potential complications such as community-acquired pneumonia (CAP) are becoming more apparent. Paradoxically, in spite of an increased focus on potential complications, there is an increased use of acid suppressants in children and a lack of data specifically targeting the association between acid suppressants and CAP. Our main objective was to evaluate the risk of CAP in children using acid suppressants (proton pump inhibitors (PPIs) and/or histamine-2 receptor antagonists (H2RAs)). METHODS: We performed a cohort study using data from the UK Clinical Practice Research Datalink. All patients aged 1 month to 18 years with a prescription of acid suppressants were included and matched to up to four unexposed children. Time-varying Cox proportional hazards models were used to estimate the risk of CAP. The cohort consisted of 84 868 exposed and 325 329 unexposed children. RESULTS: Current use of PPIs and H2RAs was associated with an increased risk of CAP (adjusted hazard ratio 2.05 (95% CI 1.90-2.22) and 1.80 (95% CI 1.67-1.94), respectively). The risk was even greater in patients with respiratory disease. Long-term use (≥211 days) of PPIs and H2RAs led to a significantly greater risk of CAP compared with short-term use (<31 days). After cessation of therapy, the risk remained increased for the following 7 months. CONCLUSION: The use of acid suppressants in children was associated with a doubled risk of CAP. This risk increased with chronic use and respiratory disease, and remained increased after discontinuation of therapy.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. van der Sande LJTM, Jöbsis Q, Bannier MAGE, et al. The risk of community-acquired pneumonia in children using gastric acid suppressants. Eur Respir J. 2021. PMID: 33737412. doi:10.1183/13993003.03229-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。